Table 1.

Demographic features of patients with Crohn's disease (CD).

Variable	n = 21
Age (year)	40.2 ± 16.1 (17–71)
Gender (male/female)	14/7
Duration of disease (year)	7.86 ± 7.1 (0–22)
Age at diagnosis (year)	32.3 ± 16.1 (14–65)
Montreal classification
A1/A2/A3	1 (4.8%) / 14 (66.7%) / 6 (28.5%)
L1/L2/L3/L4	13 (61.9%) / 0 (0.0%) / 8 (38.1%) / 0 (0%)
B1/B2/B3	14 (66.7%) / 4 (19.0%) / 3 (14.3%)
Smoking	11 (52.4%)
Surgery required	7 (33.3%)
Length of resected small bowel (cm)	21.3 ± 3.7 (17–30)
Perianal disease	5 (23.8%)
Concomitant use
5-Aminosalicylates	20 (95.2%)
Immunomodulators	8 (38.1%)
Elemental diet	8 (38.1%)
Biologics	9 (42.9%)
CDAI (points)	69.5 ± 37.9 (20–141)
LS (points)	583.7 ± 1061.8 (0–3720)
CECDAI (points)	3.8 ± 3.7 (0–13)
Small bowel transit time (min)	235.7 ± 116.9 (42–554)
CRP (mg/dL)	0.14 ± 0.16
Hb (g/dL)	13.6 ± 1.4
Alb (g/dL)	4.3 ± 0.4

A1 below16y, A2 between17 and 40y, A3 above 40y.

L1 ileal, L2 colonic, L3 ileocolonic, L4 isolated upper disease.

B1 non-stricturing, non-penetrating, B2 stricturing, B3 penetrating.

CDAI Crohn's disease activity index.

LS Lewis capsule endoscopy scoring index.

CECDAI Capsule endoscopy Crohn's disease activity index scoring system.